Carl Sciacchitano

U.S. Food and Drug Administration
Silver Spring, MD
USA

Papers:
Collaboration with Chinese Regulatory Counterparts
FDA’s Update on Global Laboratory and PT Capacity Building and Its Effect on FSMA: Testing at Country of Origin